![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Virological Outcomes and Adherence to Treatment Algorithms in a Longitudinal Study of Patients with Chronic Hepatitis C Treated with Boceprevir or Telaprevir in the U.S. (HCV-TARGET)
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
AM Di Bisceglie, A Kuo, VK Rustgi, MS Sulkowski,
TG Stewart, JM Fenkel, H ElGenaidi, M Mah'moud, GM Abraham, MW Fried, RK Sterling
for the HCV-TARGET Study Group
![AASLD1.gif](../images/111213/111213-1/AASLD1.gif)
![AASLD2.gif](../images/111213/111213-1/AASLD2.gif)
![AASLD3.gif](../images/111213/111213-1/AASLD3.gif)
![AASLD4.gif](../images/111213/111213-1/AASLD4.gif)
![AASLD5.gif](../images/111213/111213-1/AASLD5.gif)
![AASLD6.gif](../images/111213/111213-1/AASLD6.gif)
![AASLD7.gif](../images/111213/111213-1/AASLD7.gif)
![AASLD8.gif](../images/111213/111213-1/AASLD8.gif)
![AASLD9.gif](../images/111213/111213-1/AASLD9.gif)
![AASLD10.gif](../images/111213/111213-1/AASLD10.gif)
![AASLD11.gif](../images/111213/111213-1/AASLD11.gif)
![AASLD12.gif](../images/111213/111213-1/AASLD12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|